Prevalence and Factors Associated with Drug-resistant Epilepsy Among Children Attending the Pediatric Neurology Clinic at an Urban Tertiary Hospital in Uganda
Keywords:
epilepsy, drug resistant epilepsy, antiseizure medication, child meurologyAbstract
Background: Epilepsy is among the most prevalent and serious neurological diseases. Anti-seizure medications are still the mainstay of management in most epilepsies. Globally, 10-40% of patients are estimated to have drug resistant epilepsy (DRE). However, there is limited data regarding DRE among children in low resource settings. Objective: This study aimed at determining the prevalence and factors associated with DRE among children with epilepsy in a large pediatric neurology clinic in Uganda. Methods: A cross-sectional study was performed between April and June 2023. Children aged 1 to 17 years with epilepsy, who had been on antiseizure medication (ASM) for at least 12 months, were recruited. Results: The prevalence of DRE was 12.2% (34/278); (95% CI: 8.6 – 16.7%). Factors associated with DRE included; multiple seizure episodes [APR=6.5, 95% CI: 3.3-17.4, P<0.0001], multiple seizure types [APR=4.4, 95% CI: 3.0-9.4, P<0.0001], diagnosis of an epilepsy syndrome [APR=3.6, 95% CI: 2.5-8.3, P=0.026], prior history of status epilepticus [APR=3.6, 95% CI: 2.7-6.1, P=0.001], focal seizure type [APR=2.3, 95% CI: 1.3-4.2, P=0.002], and symptomatic epilepsy [APR=2.1, 95% CI: 1.4-3.8, P=0.041]. Conclusion: The 12.2% prevalence of DRE estimated in this study is still high. Lower-level clinicians should be on higher alert for children with high risk factors for DRE like; multiple frequent seizures types, likely developmental and epileptic encephalopathies (DEE) and symptomatic epilepsy for timely referral to tertiary epilepsy specialized care. The study further underscores the need to make epilepsy syndromes part of routine epilepsy care.
References
Song P, Liu Y, Yu X, Wu J, Poon AN, Demaio A, et al, Global Health Epidemiology Research Group. Prevalence of epilepsy in China between 1990 and 2015: a systematic review and meta–analysis. Journal of global health. 2017 Dec;7(2). 10.7189/jogh.07-020706
Fiest KM, Sauro KM, Wiebe S, Patten SB, Kwon CS, Dykeman J, et al, Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology. 2017 Jan 17;88(3):296-303. https://doi.org/10.1212/WNL.0000000000003509
Kakooza‐MA, Ndyomugyenyi D, Pariyo G, Peterson SS, Waiswa PM, Galiwango E, et al, Adverse perinatal events, treatment gap, and positive family history linked to the high burden of active convulsive epilepsy in Uganda: a population‐based study. Epilepsia Open. 2017 Jun;2(2):188-98. https://doi.org/10.1002/epi4.12048
Sultana B, Panzini MA, Veilleux Carpentier A, Comtois J, Rioux B, Gore G, et al, Incidence and prevalence of drug-resistant epilepsy: a systematic review and meta-analysis. Neurology. 2021 Apr 27;96(17):805-17. https://doi.org/10.1212/WNL.0000000000011839
Mangunatmadja I, Indra RM, Widodo DP, Rafli A. Risk Factors for Drug Resistance in Epileptic Children with Age of Onset above Five Years: A Case‐Control Study. Behavioural Neurology. 2021;2021(1):9092824. https://doi.org/10.1155/2021/9092824
Orozco-Hernández JP, Quintero-Moreno JF, Marín-Medina DS, Valencia-Vásquez A, Villada HC, Lizcano A, Martínez JW. Multivariable prediction model of drug resistance in adult patients with generalized epilepsy from Colombia: a case–control study. Epilepsy & Behavior. 2018 Nov 1; 88:176-80. https://doi.org/10.1016/j.yebeh.2018.09.025
World Health Organization. Intersectoral global action plan on Epilepsy and other neurological disorders 2022–2031. World Health Organization; 2023 Jul 20.
Kissani N, Nafia S, El Khiat A, Bengamara N, Maiga Y, Sogoba Y, et al, Epilepsy surgery in Africa: state of the art and challenges. Epilepsy & Behavior. 2021 May 1; 118:107910. https://doi.org/10.1016/j.yebeh.2021.107910
Pellinen J. Treatment gaps in epilepsy. Frontiers in Epidemiology. 2022 Aug 1; 2:976039. https://doi.org/10.3389/fepid.2022.976039
Mohammadzadeh P, Nazarbaghi S. The prevalence of drug-resistant-epilepsy and its associated factors in patients with epilepsy. Clinical neurology and neurosurgery. 2022 Feb 1; 213:107086. https://doi.org/10.1016/j.clineuro.2021.107086
Urio OH. Prevalence of intractable epilepsy and associated factors among children with epilepsies attending paediatric neurology clinic at m-Muhimbili national hospital, Dar es salaam, Tanzania (Doctoral dissertation, Muhimbili University of Health and Allied Sciences). http://dspace.muhas.ac.tz:8080/xmlui/handle/123456789/2951
Atugonza R, Kakooza-MA, Lhatoo S, Kaddumukasa M, Mugenyi L, Sajatovic M, et al, Multiple anti-epileptic drug use in children with epilepsy in Mulago hospital, Uganda: a cross-sectional study. BMC pediatrics. 2016 Dec; 16:1-0. https://doi.org/10.1186/s12887-016-0575-0
Kandawasvika GQ, Dingiswayo P, Kaisi D, Ngara B. Paediatric epilepsy: The status and challenges of care in Zimbabwe. Central African Journal of Medicine. 2019 Nov 29;65(4-6):40-5.
Adal HD, Alemu K, Muche EA. Seizure control status and associated factors among pediatric epileptic patients at a neurologic outpatient clinic in Ethiopia. Plos one. 2021 Nov 3;16(11):e0259079. https://doi.org/10.1371/journal.pone.0259079
Zena D, Tadesse A, Bekele N, Yaregal S, Sualih N, Worku E. Seizure control and its associated factors among epileptic patients at Neurology Clinic, University of Gondar hospital, Northwest Ethiopia. SAGE Open Medicine. 2022 May; 10:20503121221100612. https://doi.org/10.1177/20503121221100612
Cerulli Irelli E, Morano A, Barone FA, Fisco G, Fanella M, Orlando B, Fattouch J, et al, Persistent treatment resistance in genetic generalized epilepsy: a long‐term outcome study in a tertiary epilepsy center. Epilepsia. 2020 Nov;61(11):2452-60. https://doi.org/10.1111/epi.16708
Choi H, Detyniecki K, Bazil C, Thornton S, Crosta P, Tolba H, Muneeb M, et al, Development and validation of a predictive model of drug-resistant genetic generalized epilepsy. Neurology. 2020 Oct 13;95(15):e2150-60. https://doi.org/10.1212/WNL.0000000000010597
Karaoğlu P, Yiş U, Polat Aİ, Ayanoğlu M, Hiz AS. Clinical predictors of drug-resistant epilepsy in children. Turkish Journal of Medical Sciences. 2021;51(3):1249-52. DOI; 10.3906/sag-2010-27
Xue-Ping W, Hai-Jiao W, Li-Na Z, Xu D, Ling L. Risk factors for drug-resistant epilepsy: A systematic review and meta-analysis. Medicine. 2019 Jul 1;98(30): e16402. DOI: 10.1097/MD.0000000000016402
Kobow K, Baulac S, von Deimling A, Lee JH. Molecular diagnostics in drug‐resistant focal epilepsy define new disease entities. Brain pathology. 2021 Jul;31(4): e12963. https://doi.org/10.1111/bpa.12963
Apolot D, Erem G, Nassanga R, Kiggundu D, Tumusiime CM, Teu A, Mugisha AM, Sebunya R. Brain magnetic resonance imaging findings among children with epilepsy in two urban hospital settings, Kampala-Uganda: a descriptive study. BMC Medical Imaging. 2022 Oct 6;22(1):175. https://doi.org/10.1186/s12880-022-00901-7
Huang L, Li S, He D, Bao W, Li L. A predictive risk model for medical intractability in epilepsy. Epilepsy & Behavior. 2014 Aug 1; 37:282-6. https://doi.org/10.1016/j.yebeh.2014.07.002
Kwan P, Schachter SC, Brodie MJ. Drug-resistant epilepsy. New England Journal of Medicine. 2011 Sep 8;365(10):919-26. DOI: 10.1056/NEJMra1004418
Kalilani L, Sun X, Pelgrims B, Noack‐Rink M, Villanueva V. The epidemiology of drug‐resistant epilepsy: a systematic review and meta‐analysis. Epilepsia. 2018 Dec;59(12):2179-93. https://doi.org/10.1111/epi.14596
Pal DK, Greenberg DA. Evaluating genetic heterogeneity in complex disorders. Human heredity. 2002 Nov 21;53(4):216-26. https://doi.org/10.1159/000066195
Wang J, Wen Y, Zhang Q, Yu S, Chen Y, Wu X, et al, Gene mutational analysis in a cohort of Chinese children with unexplained epilepsy: Identification of a new KCND3 phenotype and novel genes causing Dravet syndrome. Seizure. 2019 Mar 1; 66:26-30. https://doi.org/10.1016/j.seizure.2019.01.025
Chen Z, Brodie MJ, Liew D, Kwan P. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study. JAMA neurology. 2018 Mar 1;75(3):279-86. doi:10.1001/jamaneurol.2017.3949
Saygi S, Erol I, Alehan F. Early clinical predictors of intractable epilepsy in childhood. Turkish journal of medical sciences. 2014;44(3):490-5. doi; 10.3906/sag-1302-4
Downloads
Published
License
Copyright (c) 2025 East African Journal of Neurological Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
